GNVC:NASDAQ $.99 + $.12: $3.50 Merriman Target Phase 3 results to date indicate GNVC Cancer drug has results bettee than DNDN which went to $25. Merriman gives $3.50 target. <a href="http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks_G/threadview?m=tm&bn=7976&tid=61708&mid=61708&tof=12&frt=1" rel="nofollow" target="_blank">http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks_G/threadview?m=tm&bn=7976&tid=61708&mid=61708&tof=12&frt=1</a>